EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk

Metehan Ozen iD, Hugues Piloquet, Monika Schaubeck

Nutrients · 2023

DOI: 10.3390/nu15092207 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2023. Verfasst von Metehan Ozen und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Acibadem Mehmet Ali Aydinlar University, 34752 Istanbul, Türkiye. Hauptthemen laut MEDLINE: Limosilactobacillus fermentum, Probiotics. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HiPP GmbH & Co. Vertrieb KG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breastfeeding provides the ideal nutrition for infants. Human milk contains a plethora of functional ingredients which foster the development of the immune system. The human milk microbiota predominantly contributes to this protective effect. This is mediated by various mechanisms, such as an antimicrobial effect, pathogen exclusion and barrier integrity, beneficial effects on the gastrointestinal microbiota, vitamin synthesis, immunity enhancement, secreted probiotic factors, and postbiotic mechanisms. Therefore, human milk is a good source for isolating probiotics for infants who cannot be exclusively breastfed. One such probiotic which was isolated from human milk is Limosilactobacillus fermentum CECT5716. In this review, we give an overview of available interventional studies using Limosilactobacillus fermentum CECT5716 and summarise preclinical trials in several animal models of different pathologies, which have given first insights into its mechanisms of action. We present several randomised clinical studies, which have been conducted to investigate the clinical efficacy of the Limosilactobacillus fermentum CECT5716 strain in supporting the host’s health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Limosilactobacillus fermentumProbioticsAnimalsInfantFemaleHumansMilk, HumanBreast FeedingBiological Transport

Stichwörter der Autor:innen

Lactobacillus fermentum CECT5716Limosilactobacillus fermentum CECT5716diarrhoeahuman milkinfant formulainfant microbiotaprobioticrespiratory tract infections

Autor:innen und Institutionen

  • School of Medicine, Acibadem Mehmet Ali Aydinlar University, 34752 Istanbul, Türkiye.
  • Department of Paediatric Chronic Diseases, Nantes University Hospital, 44000 Nantes, France.
  • HiPP GmbH & Co. Vertrieb KG, 85276 Pfaffenhofen, Germany.

ORCID-Profile: Metehan Ozen

Förderung

  • HiPP GmbH & Co. Vertrieb KG

Zitieren

APA

Ozen, M., Piloquet, H., & Schaubeck, M. (2023). Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk. Nutrients. https://doi.org/10.3390/nu15092207

Vancouver

Ozen M, Piloquet H, Schaubeck M. Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk. Nutrients. 2023. doi:10.3390/nu15092207

BibTeX
@article{Ozen2023,
  author = {Ozen, Metehan and Piloquet, Hugues and Schaubeck, Monika},
  title = {Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15092207}
}
Kostenlos starten →